dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Gamez Carbonell, Josep |
dc.contributor.author | Salvadó Figueras, Maria |
dc.contributor.author | Carmona-Herrera, Francisco |
dc.contributor.author | Nadal Clanchet, Miriam de |
dc.contributor.author | Romero Vielva, Laura Maria |
dc.contributor.author | Ruiz, Daniel |
dc.contributor.author | Jauregui Abularach, Alberto |
dc.contributor.author | Pérez Vélez, Javier |
dc.contributor.author | Suñe Martin, Pilar |
dc.contributor.author | Deu Martín, María |
dc.date.accessioned | 2020-02-18T09:12:58Z |
dc.date.available | 2020-02-18T09:12:58Z |
dc.date.issued | 2019-07-17 |
dc.identifier.citation | Gamez J, Salvadó M, Carmona F, de Nadal M, Romero L, Ruiz D, et al. Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis. Ther Adv Neurol Disord. 2019 Jul 17;12:175628641986449. |
dc.identifier.issn | 1756-2856 |
dc.identifier.uri | https://hdl.handle.net/11351/4651 |
dc.description | Immunoglobulina; Miastènia; Timectomia |
dc.description.sponsorship | This work was funded by a Fondo de Investigacion Sanitaria (FIS-FEDER) (grants PI16-01673 and PI19/00593) and an Interlaken Research Award Programme (2012-12094537) |
dc.language.iso | eng |
dc.publisher | SAGE Publications |
dc.relation.ispartofseries | Therapeutic Advances in Neurological Disorders;12 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Miastènia greu pseudoparalítica |
dc.subject | Timectomia |
dc.subject | Immunoglobulines |
dc.subject.mesh | Myasthenia Gravis |
dc.subject.mesh | Thymectomy |
dc.subject.mesh | Immunoglobulins, Intravenous |
dc.title | Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1177/1756286419864497 |
dc.subject.decs | miastenia gravis |
dc.subject.decs | timectomía |
dc.subject.decs | inmunoglobulinas intravenosas |
dc.relation.publishversion | https://journals.sagepub.com/doi/10.1177/1756286419864497 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Gamez J] Servei de Neurologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Newcastle University, UK. Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. [Salvadó M] Servei de Neurologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. [Carmona F] Department of Genetics, Microbiology and Statistics, University of Barcelona, Barcelona, Spain. [De Nadal M] Department of Anesthesiology and Intensive Care, Universitat Autònoma de Barcelona, Barcelona, Spain. [Romero, L, Jáuregui A, Pérez J, Deu M] Servei de Cirurgia Toràcica, Hospital Universitari Vall d’Hebron, Barcelona, Spain. [Ruiz D] Department of Anesthesiology and Intensive Care, Universitat Autònoma de Barcelona, Barcelona, Spain. [Suñé P] Servei de Farmàcia, Hospital Universitari Vall d’Hebron, Barcelona, Spain |
dc.identifier.pmid | 31360225 |
dc.identifier.wos | 000478600400001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |